Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 2
1967 2
1968 3
1969 3
1970 3
1971 7
1972 4
1973 3
1974 10
1975 8
1976 11
1977 7
1978 11
1979 9
1980 10
1981 5
1982 5
1983 3
1984 2
1985 7
1986 10
1987 4
1988 5
1990 6
1991 10
1992 8
1993 10
1994 6
1995 13
1996 10
1997 14
1998 23
1999 23
2000 16
2001 15
2002 9
2003 9
2004 8
2005 8
2006 8
2007 5
2008 10
2009 7
2010 2
2011 6
2012 5
2013 3
2014 5
2015 5
2016 1
2017 4
2018 2
2019 4
2020 8
2021 16
2022 13
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

424 results

Results by year

Filters applied: . Clear all
Page 1
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial.
Caimi PF, Ai W, Alderuccio JP, Ardeshna KM, Hamadani M, Hess B, Kahl BS, Radford J, Solh M, Stathis A, Zinzani PL, Havenith K, Feingold J, He S, Qin Y, Ungar D, Zhang X, Carlo-Stella C. Caimi PF, et al. Among authors: feingold j. Lancet Oncol. 2021 Jun;22(6):790-800. doi: 10.1016/S1470-2045(21)00139-X. Epub 2021 May 11. Lancet Oncol. 2021. PMID: 33989558 Clinical Trial.
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma.
Hamadani M, Radford J, Carlo-Stella C, Caimi PF, Reid E, O'Connor OA, Feingold JM, Ardeshna KM, Townsend W, Solh M, Heffner LT, Ungar D, Wang L, Boni J, Havenith K, Qin Y, Kahl BS. Hamadani M, et al. Among authors: feingold jm. Blood. 2021 May 13;137(19):2634-2645. doi: 10.1182/blood.2020007512. Blood. 2021. PMID: 33211842 Free PMC article. Clinical Trial.
Hip-Spine Syndrome in the Nonarthritic Patient.
Vaswani R, White AE, Feingold J, Ranawat AS. Vaswani R, et al. Among authors: feingold j. Arthroscopy. 2022 Oct;38(10):2930-2938. doi: 10.1016/j.arthro.2022.04.015. Epub 2022 May 10. Arthroscopy. 2022. PMID: 35550420
Genetics of Alport's syndrome.
Feingold J, Bois E. Feingold J, et al. Pediatr Nephrol. 1987 Jul;1(3):436-8. doi: 10.1007/BF00849250. Pediatr Nephrol. 1987. PMID: 3153314 Review.
The presymptomatic phase of Huntington disease.
Durr A, Gargiulo M, Feingold J. Durr A, et al. Among authors: feingold j. Rev Neurol (Paris). 2012 Nov;168(11):806-8. doi: 10.1016/j.neurol.2012.07.003. Epub 2012 Aug 15. Rev Neurol (Paris). 2012. PMID: 22902173 Review.
[Hereditary nephropathies].
Royer P, Frezal J, Bois E, Feingold J. Royer P, et al. Among authors: feingold j. Arch Fr Pediatr. 1970 Mar;27(3):293-317. Arch Fr Pediatr. 1970. PMID: 4916279 Review. French. No abstract available.
424 results